Abstract
Background: Previous studies have speculated that a viral infection may act as a trigger in the development of idiopathic dilated cardiomyopathy (DCM) among individuals genetically at risk. This study aims to describe the frequency of DCM patients who reported experiencing symptoms of flu-like illness prior to their DCM diagnosis and to examine if this experience modified the association between genetics and DCM. Methods: We analyzed data from the family-based cross-sectional DCM Study conducted between 2016 and 2021. Self-reported symptoms of flu-like illness proximal to DCM diagnosis were obtained from patient interview. Exome sequencing identified rare variants [pathogenic (P), likely pathogenic (LP), or uncertain significance (VUS)] in DCM genes. In a case-only design, logistic mixed models were used to examine if flu-like illness modified the effect of these rare variants on DCM risk. Firth logistic regression was used to examine if flu-like illness modified the effect of each of 13,400,141 common autosomal variants (minor allele frequency ≥1%) on DCM risk. Results: Of 1,164 DCM patients, 30.2% reported symptoms of flu-like illness proximal to DCM diagnosis. The percentage of patients with antecedent flu-like illness by variant classification was 30.0% for P/LP, 29.6% for VUS only, and 30.0% for no P/LP/VUS. Antecedent flu-like illness was not found to modify the effect of carrying any P, LP or VUS variants on DCM risk (interaction relative risk =0.9, 95% CI: 0.7-1.3). However, significant modification of the effect of rs2102158 (3q24) by antecedent flu-like illness (p=2.74x10-8) was identified by case-only genome-wide association study (GWAS). Conclusions: Approximately one-third of DCM patients experienced flu-like illness symptoms prior to DCM diagnosis. We did not find evidence that a flu-like illness modified the effect of rare variants on DCM risk; however, our GWAS analysis suggested that flu-like illness may modify the effect of a common variant on DCM risk.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by a parent award from the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R01HL128857 (Dr. Hershberger), which included a supplement from the National Human Genome Research Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. None of the authors or institutions received any payments or services from third parties to support this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Boards at the Ohio State University and the initial 12 clinical sites approved the study;10 oversight was ceded to a single IRB at the University of Pennsylvania as clinical sites beyond 12 were added
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The manuscript has had minor changes and updates due to peer review. Also the Data Supplement has now been added.
Data Availability
Data are available via dbGaP.
